Published in Biochem Biophys Res Commun on October 05, 2013
Retracted Role of microRNAs in diagnosis and treatment of the pathogenesis of gastric cancer. Int J Clin Exp Med (2014) 0.83
MicroRNA let-7b suppresses human gastric cancer malignancy by targeting ING1. Cancer Gene Ther (2015) 0.81
MicroRNA-126 regulates migration and invasion of gastric cancer by targeting CADM1. Int J Clin Exp Pathol (2015) 0.79
The role of gastrokine 1 in gastric cancer. J Gastric Cancer (2014) 0.78
Trophoblast expression dynamics of the tumor suppressor gene gastrokine 2. Histochem Cell Biol (2015) 0.77
The up-regulation of miR-300 in gastric cancer and its effects on cells malignancy. Int J Clin Exp Med (2015) 0.77
Nucleostemin regulates proliferation and migration of gastric cancer and correlates with its malignancy. Int J Clin Exp Med (2015) 0.76
Red blood cell transfusions are associated with lower mortality in patients with severe sepsis and septic shock: a propensity-matched analysis*. Crit Care Med (2012) 5.35
PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene (2005) 4.07
Incremental predictive value of red cell distribution width for 12-month clinical outcome after acute myocardial infarction. Clin Cardiol (2013) 2.05
Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas. Clin Cancer Res (2006) 1.98
Increased expression of histone deacetylase 2 is found in human gastric cancer. APMIS (2005) 1.77
Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence. Vaccine (2010) 1.75
Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res (2003) 1.73
Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck. Clin Cancer Res (2005) 1.70
Influenza vaccine coverage rates and perceptions on vaccination in South Korea. J Infect (2007) 1.69
Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Virol (2006) 1.62
Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology (2003) 1.56
Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Hepatology (2013) 1.49
Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Hepatology (2005) 1.48
18F-FDG PET CT as a prognostic factor in hepatocellular carcinoma. Turk J Gastroenterol (2015) 1.40
Somatic mutations of the ERBB4 kinase domain in human cancers. Int J Cancer (2006) 1.38
Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood (2002) 1.30
BRAF and KRAS mutations in stomach cancer. Oncogene (2003) 1.27
Genetic alterations of the KLF6 gene in gastric cancer. Oncogene (2005) 1.26
Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1. Biochem Biophys Res Commun (2002) 1.23
ArrayCyGHt: a web application for analysis and visualization of array-CGH data. Bioinformatics (2005) 1.23
Altered expression of the KLF4 in colorectal cancers. Pathol Res Pract (2006) 1.23
CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res (2005) 1.20
Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas. Virchows Arch (2005) 1.20
ERBB2 kinase domain mutation in the lung squamous cell carcinoma. Cancer Lett (2005) 1.19
Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea. Vaccine (2011) 1.18
MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer. Cancer Lett (2013) 1.17
Decreased expression of tumour suppressor Bax-interacting factor-1 (Bif-1), a Bax activator, in gastric carcinomas. Pathology (2006) 1.16
Aberrant regulation of HDAC2 mediates proliferation of hepatocellular carcinoma cells by deregulating expression of G1/S cell cycle proteins. PLoS One (2011) 1.12
Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis. Liver Int (2005) 1.11
Immunogenicity and safety of the influenza A/H1N1 2009 inactivated split-virus vaccine in young and older adults: MF59-adjuvanted vaccine versus nonadjuvanted vaccine. Clin Vaccine Immunol (2011) 1.11
Immunohistochemical expression of integrins and extracellular matrix proteins in non-small cell lung cancer: correlation with lymph node metastasis. Lung Cancer (2003) 1.11
Clinical and microbiological characterization of carbapenem-resistant Acinetobacter baumannii bloodstream infections. J Med Microbiol (2011) 1.09
Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225_1226delTG in hepatocellular carcinomas. Oncogene (2005) 1.09
Increased expression of FLIP, an inhibitor of Fas-mediated apoptosis, in stomach cancer. APMIS (2003) 1.08
Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma. J Cell Biochem (2010) 1.07
Loss of caspase-2, -6 and -7 expression in gastric cancers. APMIS (2004) 1.06
Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumors. Oncogene (2005) 1.06
Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer. APMIS (2003) 1.05
Somatic mutations of CASP3 gene in human cancers. Hum Genet (2004) 1.05
Inactivation of the Gastrokine 1 gene in gastric adenomas and carcinomas. J Pathol (2011) 1.04
Comparing fluorescence in situ hybridization and chromogenic in situ hybridization methods to determine the HER2/neu status in primary breast carcinoma using tissue microarray. Mod Pathol (2003) 1.04
Supported core@shell electrocatalysts for fuel cells: close encounter with reality. Sci Rep (2013) 1.03
Hospital-based influenza surveillance in Korea: hospital-based influenza morbidity and mortality study group. J Med Virol (2013) 1.01
PDCD4 expression inversely correlated with miR-21 levels in gastric cancers. J Cancer Res Clin Oncol (2012) 1.01
Gastrokine 1 functions as a tumor suppressor by inhibition of epithelial-mesenchymal transition in gastric cancers. J Cancer Res Clin Oncol (2011) 1.01